Georgiana Purdy

Georgiana Purdy


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SPSophia A. Pacheco
Sophia A. Pacheco
FHFong-Fu Hsu
Fong-Fu Hsu
KPKatelyn M. Powers
Katelyn M. Powers
GPGeorgiana Purdy
Georgiana Purdy
A growing body of evidence indicates that MmpL (mycobacterial membrane protein large) transporters are dedicated to cell wall biosynthesis and transport mycobacterial lipids. How MmpL transporters function and the identities of their substrates have not been fully elucidated. We report the characterization of Mycobacterium smegmatis MmpL11. We showed previously that M. smegmatis lacking MmpL11 has reduced membrane permeability that results in resistance to host antimicrobial peptides. We report herein the further characterization of the M. smegmatis mmpL11 mutant and identification of the MmpL11 substrates. We found that biofilm formation by the M. smegmatis mmpL11 mutant was distinct from that by wild-type M. smegmatis. Analysis of cell wall lipids revealed that the mmpL11 mutant failed to export the mycolic acid-containing lipids monomeromycolyl diacylglycerol and mycolate ester wax to the bacterial surface. In addition, analysis of total lipids indicated that the mycolic acid-containing precursor molecule mycolyl phospholipid accumulated in the mmpL11 mutant compared with wild-type mycobacteria. MmpL11 is encoded at a chromosomal locus that is conserved across pathogenic and nonpathogenic mycobacteria. Phenotypes of the M. smegmatis mmpL11 mutant are complemented by the expression of M. smegmatis or M. tuberculosis MmpL11, suggesting that MmpL11 plays a conserved role in mycobacterial cell wall biogenesis.

5 March 2019 in Microorganisms
Verified
Journal Article
Open access
PDF file
GMGeoff Melly
Geoff Melly
GPGeorgiana Purdy
Georgiana Purdy
Mycobacterium tuberculosis (Mtb) remains an important human pathogen. The Mtb cell envelope is a critical bacterial structure that contributes to virulence and pathogenicity. Mycobacterial membrane protein large (MmpL) proteins export bulky, hydrophobic substrates that are essential for the unique structure of the cell envelope and directly support the ability of Mtb to infect and persist in the host. This review summarizes recent investigations that have enabled insight into the molecular mechanisms underlying MmpL substrate export and the role that these substrates play during Mtb infection.

24 August 2009 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
GPGeorgiana Purdy
Georgiana Purdy
MNMichael Niederweis
Michael Niederweis
DRDavid Russell
David Russell
Summary: Ubiquitin‐derived peptides are bactericidal in vitro and contribute to the mycobactericidal activity of the lysosome. To further define interactions of ubiquitin‐derived peptides with mycobacteria, we screened for mutants with increased resistance to the bactericidal activity of the synthetic ubiquitin‐derived peptide Ub2. The four Ub2‐resistant Mycobacterium smegmatis mutants were also resistant to the bactericidal action of other antimicrobial peptides and macrophages. Two mutants were in the mspA gene encoding the main M. smegmatis porin. Using a translocation‐deficient MspA point mutant, we showed that susceptibility of M. smegmatis to Ub2 was independent of MspA channel activity. Instead, the M. smegmatis Ub2‐resistant mutants shared a common phenotype of decreased cell wall permeability compared with wild‐type bacteria. Expression of mspA rendered Mycobacterium tuberculosis CDC1551 more susceptible both to ubiquitin‐derived peptides in vitro and to lysosomal killing in macrophages. Finally, biochemical assays designed to assess membrane integrity indicated that Ub2 treatment impairs membrane function of M. smegmatis and M. tuberculosis cells. The M. smegmatis Ub2‐resistant mutants were more resistant than wild‐type M. smegmatis to this damage. We conclude that Ub2 targets mycobacterial membranes and that reduced membrane permeability provides mycobacteria intrinsic resistance against antimicrobial compounds including bactericidal ubiquitin‐derived peptides.

1 August 2017 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
CWCatherine C. Wright
Catherine C. Wright
FHFong Fu Hsu
Fong Fu Hsu
EAEusondia Arnett
Eusondia Arnett
JDJennifer L. Dunaj
Jennifer L. Dunaj
PDPatrick M. Davidson
Patrick M. Davidson
GPGeorgiana Purdy
Georgiana Purdy
The mycobacterial cell wall is crucial to the host-pathogen interface, because it provides a barrier against antibiotics and the host immune response. In addition, cell wall lipids are mycobacterial virulence factors. Themycobacterialmembraneproteinlarge (MmpL) proteins are cell wall lipid transporters that are important for basic mycobacterial physiology andMycobacterium tuberculosispathogenesis. MmpL3 and MmpL11 are conserved across pathogenic and nonpathogenic mycobacteria, a feature consistent with an important role in the basic physiology of the bacterium. MmpL3 is essential and transports trehalose monomycolate to the mycobacterial surface. In this report, we characterize the role of MmpL11 inM. tuberculosis. M. tuberculosismmpL11mutants have altered biofilms associated with lower levels of mycolic acid wax ester and long-chain triacylglycerols than those for wild-type bacteria. While the growth rate of themmpL11mutant is similar to that of wild-typeM. tuberculosisin macrophages, the mutant exhibits impaired survival in anin vitrogranuloma model. Finally, we show that the survival or recovery of themmpL11mutant is impaired when it is incubated under conditions of nutrient and oxygen starvation. Our results suggest that MmpL11 and its cell wall lipid substrates are important for survival in the context of adaptive immune pressure and for nonreplicating persistence, both of which are critically important aspects ofM. tuberculosispathogenicity.

1 October 2019 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
GMGeoff Melly
Geoff Melly
HSHaley Stokas
Haley Stokas
JDJennifer L. Dunaj
Jennifer L. Dunaj
FHFong Fu Hsu
Fong Fu Hsu
MRMalligarjunan Rajavel
Malligarjunan Rajavel
GPGeorgiana Purdy
Georgiana Purdy
The mycobacterial cell envelope is crucial to host–pathogen interactions as a barrier against antibiotics and the host immune response. In addition, cell envelope lipids are mycobacterial virulence factors. Cell envelope lipid biosynthesis is the target of a number of frontline tuberculosis treatments and has been the focus of much research. However, the transport mechanisms by which these lipids reach the mycomembrane remain poorly understood. Many envelope lipids are exported from the cytoplasm to the periplasmic space via the mycobacterial membrane protein large (MmpL) family of proteins. In other bacteria, lipoproteins can contribute to outer membrane biogenesis through direct binding of substrates and/or protein–protein associations with extracytoplasmic biosynthetic enzymes. In this report, we investigate whether the lipoprotein LpqN plays a similar role in mycobacteria. Using a genetic two-hybrid approach, we demonstrate that LpqN interacts with periplasmic loop domains of the MmpL3 and MmpL11 transporters that export mycolic acid–containing cell envelope lipids. We observe that LpqN also interacts with secreted cell envelope biosynthetic enzymes such as Ag85A via pulldown assays. The X-ray crystal structures of LpqN and LpqN bound to dodecyl-trehalose suggest that LpqN directly binds trehalose monomycolate, the MmpL3 and Ag85A substrate. Finally, we observe altered lipid profiles of the ΔlpqN mutant during biofilm maturation, pointing toward a possible physiological role for the protein. The results of this study suggest that LpqN may act as a membrane fusion protein, connecting MmpL transporters with periplasmic proteins, and provide general insight into the role of lipoproteins in Mycobacterium tuberculosis cell envelope biogenesis.

13 May 2016 in ACS Infectious Diseases
Verified
Journal Article
Closed access
MFMarie H. Foss
Marie H. Foss
SPSovitj Pou
Sovitj Pou
PDPatrick M. Davidson
Patrick M. Davidson
JDJennifer L. Dunaj
Jennifer L. Dunaj
RWRolf W. Winter
Rolf W. Winter
GPGeorgiana Purdy
Georgiana Purdy